Evelo Biosciences

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have been taking advantage of secondary offerings recently. Others have been adding to their stakes in the wake of earnings reports. Conventional wisdom says that insiders...

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. Evelo Biosciences, Inc. (EVLO) will issue more than 5.3 million shares between $15 and $17 Wednesday on the Nasdaq. The Massachusetts pharmaceutical company is developing monoclonal microbial candidates to treat cancer...

After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions. Will the lean trot end? Stay tuned to the upcoming week's...